Literature DB >> 25674231

Ectopic expression of AP-2α transcription factor suppresses glioma progression.

Wenjing Su1, Juan Xia2, Xueqin Chen1, Miao Xu1, Ling Nie1, Ni Chen1, Jing Gong1, Xinglan Li1, Qiao Zhou1.   

Abstract

The transcriptional factor AP-2α is a tumor suppressor gene and is downregulated in various neoplasms including glioma. Although the level of AP-2α is negatively associated with the grade of human glioma, the specific functions of AP-2α in glioma are still unknown. In this study, we experimentally showed that artificial overexpression of AP-2α in glioma T98G and U251 cells significantly downregulated the mRNA levels of Bcl-xl, Bcl-2, c-IAP2 and survivin, together with upregulation of the Hrk mRNA levels. Reintroduction of AP-2α also induced downregulation of the protein levels of survivin and VEGF in glioma cells. In biological assays with T98G and U251 cells, AP-2α reduced tumor cell growth, increased cell death, attenuated cell migration and endothelial tube formation. The AP-2α transcription factor may play an important role in suppressing glioma progression.

Entities:  

Keywords:  AP-2 alpha; apoptosis; cell growth; glioma; invasion

Mesh:

Substances:

Year:  2014        PMID: 25674231      PMCID: PMC4314016     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  44 in total

1.  Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.

Authors:  J Gille; R A Swerlick; S W Caughman
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

2.  Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.

Authors:  M Ruiz; P Troncoso; C Bruns; M Bar-Eli
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

3.  Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.

Authors:  Wu Yin; Ni Chen; Yutao Zhang; Hao Zeng; Xueqin Chen; Yongtao He; Xiaojie Wang; Qiao Zhou
Journal:  Mod Pathol       Date:  2006-08-04       Impact factor: 7.842

4.  Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma.

Authors:  Carmen Tellez; Marya McCarty; Maribelis Ruiz; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2003-09-15       Impact factor: 5.157

5.  Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.

Authors:  B C Turner; J Zhang; A A Gumbs; M G Maher; L Kaplan; D Carter; P M Glazer; H C Hurst; B G Haffty; T Williams
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

6.  Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.

Authors:  Seiko Hirono; Hiroki Yamaue; Yutaka Hoshikawa; Shinomi Ina; Masaji Tani; Manabu Kawai; Masaru Ushijima; Masaaki Matsuura; Yuriko Saiki; Akio Saiura; Junji Yamamoto; Yoshio Miki; Tetsuo Noda
Journal:  Cancer Sci       Date:  2009-09-10       Impact factor: 6.716

7.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.

Authors:  J M Bosher; T Williams; H C Hurst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

8.  Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.

Authors:  Xiaofeng Ding; Zijian Yang; Fangliang Zhou; Fangmei Wang; Xinxin Li; Cheng Chen; Xiaofeng Li; Xiang Hu; Shuanglin Xiang; Jian Zhang
Journal:  Int J Biochem Cell Biol       Date:  2013-05-06       Impact factor: 5.085

9.  Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.

Authors:  J M Karjalainen; J K Kellokoski; M J Eskelinen; E M Alhava; V M Kosma
Journal:  J Clin Oncol       Date:  1998-11       Impact factor: 44.544

10.  Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression.

Authors:  N Jonckheere; V Fauquette; L Stechly; N Saint-Laurent; S Aubert; C Susini; G Huet; N Porchet; I Van Seuningen; P Pigny
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more
  8 in total

1.  AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer.

Authors:  Anna C Beck; Edward Cho; Jeffrey R White; Lily Paemka; Tiandao Li; Vivian W Gu; Dakota T Thompson; Kelsey E Koch; Christopher Franke; Matthew Gosse; Vincent T Wu; Shannon R Landers; Anthony J Pamatmat; Mikhail V Kulak; Ronald J Weigel
Journal:  Mol Cancer Res       Date:  2021-03-22       Impact factor: 5.852

2.  Dual control of pcdh8l/PCNS expression and function in Xenopus laevis neural crest cells by adam13/33 via the transcription factors tfap2α and arid3a.

Authors:  Vikram Khedgikar; Genevieve Abbruzzese; Ketan Mathavan; Hannah Szydlo; Helene Cousin; Dominique Alfandari
Journal:  Elife       Date:  2017-08-22       Impact factor: 8.140

3.  Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma.

Authors:  Dawei Zhang; Haiyan Li; Xiaofeng Jiang; Liangqi Cao; Zilong Wen; Xuewei Yang; Ping Xue
Journal:  J Hematol Oncol       Date:  2017-10-30       Impact factor: 17.388

4.  PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy.

Authors:  Irina Abecassis; Andrew J Sedgewick; Marjorie Romkes; Shama Buch; Tomoko Nukui; Maria G Kapetanaki; Andreas Vogt; John M Kirkwood; Panayiotis V Benos; Hussein Tawbi
Journal:  Sci Rep       Date:  2019-03-01       Impact factor: 4.996

Review 5.  The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential.

Authors:  Mohamed H Al-Sabri; Maryam Nikpour; Laura E Clemensson; Misty M Attwood; Michael J Williams; Mathias Rask-Anderson; Jessica Mwinyi; Helgi B Schiöth
Journal:  Cell Biosci       Date:  2022-09-08       Impact factor: 9.584

6.  AP-2α expression in papillary thyroid carcinoma predicts tumor progression and poor prognosis.

Authors:  Hong Rong Wu; Jian Zhang
Journal:  Cancer Manag Res       Date:  2018-08-13       Impact factor: 3.989

7.  The Transcriptional Network Structure of a Myeloid Cell: A Computational Approach.

Authors:  Jesús Espinal-Enríquez; Daniel González-Terán; Enrique Hernández-Lemus
Journal:  Int J Genomics       Date:  2017-09-30       Impact factor: 2.326

8.  Functional genomics of AP-2α and AP-2γ in cancers: in silico study.

Authors:  Damian Kołat; Żaneta Kałuzińska; Magdalena Orzechowska; Andrzej K Bednarek; Elżbieta Płuciennik
Journal:  BMC Med Genomics       Date:  2020-11-19       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.